Evidence map›Paper›PMID 38146510›Full record

ArticleFrontiers in oncology2023

Identifying brain tumor patients' subtypes based on pre-diagnostic history and clinical characteristics: a pilot hierarchical clustering and association analysis.

Simona Esposito, Emilia Ruggiero, Augusto Di Castelnuovo, Simona Costanzo, Marialaura Bonaccio, Francesca Bracone, Vincenzo Esposito, Gualtiero Innocenzi, Sergio Paolini, Chiara Cerletti and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Simona Esposito *Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy.
Emilia Ruggiero *Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy.
Augusto Di CastelnuovoMediterranea Cardiocentro, Napoli, Italy.
Simona CostanzoDepartment of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy.
Marialaura BonaccioDepartment of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy.
Francesca BraconeDepartment of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy.
Vincenzo EspositoDepartment of Neurosurgery, IRCCS Neuromed, Pozzilli, Italy.
Gualtiero InnocenziDepartment of Neurosurgery, IRCCS Neuromed, Pozzilli, Italy.
Sergio PaoliniDepartment of Neurosurgery, IRCCS Neuromed, Pozzilli, Italy.
Chiara CerlettiDepartment of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy.
Maria Benedetta DonatiDepartment of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy.
Giovanni de GaetanoDepartment of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy.
Licia IacovielloDepartment of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy.
Alessandro GialluisiDepartment of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy.
Istituto Neurologico Mediterraneo · ITClinica Mediterranea · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Central nervous system (CNS) tumors are severe health conditions with increasing incidence in the last years. Different biological, environmental and clinical factors are thought to have an important role in their epidemiology, which however remains unclear. Objective: The aim of this pilot study was to identify CNS tumor patients' subtypes based on this information and to test associations with tumor malignancy. Methods: 90 patients with suspected diagnosis of CNS tumor were recruited by the Neurosurgery Unit of IRCCS Neuromed. Patients underwent anamnestic and clinical assessment, to ascertain known or suspected risk factors including lifestyle, socioeconomic, clinical and psychometric characteristics. We applied a hierarchical clustering analysis to these exposures to identify potential groups of patients with a similar risk pattern and tested whether these clusters associated with brain tumor malignancy. Results: Out of 67 patients with a confirmed CNS tumor diagnosis, we identified 28 non-malignant and 39 malignant tumor cases. These subtypes showed significant differences in terms of gender (with men more frequently presenting a diagnosis of cancer; p = 6.0 ×10 Discussion: These preliminary data suggest that patients' profiling through unsupervised machine learning approaches may somehow help predicting the risk of being affected by a malignant form. If confirmed by further analyses in larger independent cohorts, these findings may be useful to create potential intelligent ranking systems for treatment priority, overcoming the lack of histopathological information and molecular diagnosis of the tumor, which are typically not available until the time of surgery.

Indexed as

cancer diagnosiscentral nervous system tumorsclinical characteristicscluster analysiscognitive performancemalignancypre-diagnostic historyrisk and protective factors

Identifiers

PMID38146510
PMCPMC10749422
OpenAlexW4389131889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.